Head and Neck Cancer Research: Current Trials

For a full listing of all open and accruing studies, search our Clinical Trials Database

RTOG 1008

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

A randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resecting High-risk Malignant Salivary Gland Tumors

CASE 6213

A Phase II Trial of modified FOLFOX-6 Induction Chemotherapy followed by Esophagectomy and post-operative response based chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus, gastro-esophageal junction, and gastric cardia.

NRG HN001

Advertising Policy

Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)

CASE 6316

A Phase II Study of the Addition of Pembrolizumab to Postoperative Radiotherapy in Resected High Risk Cutaneous Squamous Cell Cancer of the Head and Neck

ROCHE 1318

Advertising Policy

A Phase III Multicenter, Randomized, Double-blind Placebo-controlled Study of Atezolizumab as Adjuvant Therapy after Definitive Local Therapy in Patients with High-risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

 

 

Search the Head & Neck Cancer section of our Cancer Clinical Trials Database for a full listing of all open and accruing studies.